MYC and small cell lung carcinoma: It was found that for MYC-driven SCLC, adding pegylated arginine deiminase (ADI-PEG 20) to intervene arginine synthesis exhibited antitumor properties beyond conventional chemotherapy in GEMM, patient-derived cell line xenografts and PDX models (Chalishazar et al., 2019).